# Analog Devices Inc: financial statements, quarterly

ADI · Nasdaq · CIK 6281 · [Technology](/sectors/technology.md) · fiscal year ends Oct 31

Pages: [Overview](/companies/adi.md) · [Financials](/companies/adi/financials.md) · [Filings](/companies/adi/filings.md) · [Insiders](/companies/adi/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/adi/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-10-28) | Q1 FY2024 (2024-02-03) | Q2 FY2024 (2024-05-04) | Q3 FY2024 (2024-08-03) | Q4 FY2024 (2024-11-02) | Q1 FY2025 (2025-02-01) | Q2 FY2025 (2025-05-03) | Q3 FY2025 (2025-08-02) | Q4 FY2025 (2025-11-01) | Q1 FY2026 (2026-01-31) | Q2 FY2026 (2026-05-02) | Q3 FY2026 (2026-08-01) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [2,716 d](/filings/0000006281-25-000153.md) | [2,513](/filings/0000006281-25-000023.md) | [2,159](/filings/0000006281-25-000125.md) | [2,312](/filings/0000006281-25-000144.md) | [2,443 d](/filings/0000006281-25-000153.md) | [2,423](/filings/0000006281-26-000016.md) | [2,640](/filings/0000006281-26-000052.md) | [2,880](/filings/0000006281-26-000073.md) | [3,076 d](/filings/0000006281-25-000153.md) | [3,160](/filings/0000006281-26-000016.md) | [3,623](/filings/0000006281-26-000052.md) | [4,022](/filings/0000006281-26-000073.md) |
| Cost of revenue | $m | [1,070 d](/filings/0000006281-25-000153.md) | [1,039](/filings/0000006281-25-000023.md) | [979](/filings/0000006281-25-000125.md) | [1,001](/filings/0000006281-25-000144.md) | [1,027 d](/filings/0000006281-25-000153.md) | [993](/filings/0000006281-26-000016.md) | [1,028](/filings/0000006281-26-000052.md) | [1,091](/filings/0000006281-26-000073.md) | [1,134 d](/filings/0000006281-25-000153.md) | [1,115](/filings/0000006281-26-000016.md) | [1,184](/filings/0000006281-26-000052.md) | [1,314](/filings/0000006281-26-000073.md) |
| Gross profit | $m | [1,647 d](/filings/0000006281-25-000153.md) | [1,474](/filings/0000006281-25-000023.md) | [1,180](/filings/0000006281-25-000125.md) | [1,311](/filings/0000006281-25-000144.md) | [1,416 d](/filings/0000006281-25-000153.md) | [1,430](/filings/0000006281-26-000016.md) | [1,612](/filings/0000006281-26-000052.md) | [1,790](/filings/0000006281-26-000073.md) | [1,942 d](/filings/0000006281-25-000153.md) | [2,045](/filings/0000006281-26-000016.md) | [2,440](/filings/0000006281-26-000052.md) | [2,708](/filings/0000006281-26-000073.md) |
| Research and development | $m | [407 d](/filings/0000006281-25-000153.md) | [391](/filings/0000006281-25-000023.md) | [355](/filings/0000006281-25-000125.md) | [363](/filings/0000006281-25-000144.md) | [379 d](/filings/0000006281-25-000153.md) | [403](/filings/0000006281-26-000016.md) | [442](/filings/0000006281-26-000052.md) | [454](/filings/0000006281-26-000073.md) | [467 d](/filings/0000006281-25-000153.md) | [467](/filings/0000006281-26-000016.md) | [509](/filings/0000006281-26-000052.md) | [533](/filings/0000006281-26-000073.md) |
| Selling, general and administrative | $m | [289 d](/filings/0000006281-25-000153.md) | [290](/filings/0000006281-25-000023.md) | [244](/filings/0000006281-25-000125.md) | [257](/filings/0000006281-25-000144.md) | [277 d](/filings/0000006281-25-000153.md) | [285](/filings/0000006281-26-000016.md) | [303](/filings/0000006281-26-000052.md) | [326](/filings/0000006281-26-000073.md) | [342 d](/filings/0000006281-25-000153.md) | [345](/filings/0000006281-26-000016.md) | [363](/filings/0000006281-26-000052.md) | [397](/filings/0000006281-26-000073.md) |
| Operating income | $m | [634 d](/filings/0000006281-25-000153.md) | [586](/filings/0000006281-25-000023.md) | [386](/filings/0000006281-25-000125.md) | [491](/filings/0000006281-25-000144.md) | [569 d](/filings/0000006281-25-000153.md) | [491](/filings/0000006281-26-000016.md) | [678](/filings/0000006281-26-000052.md) | [818](/filings/0000006281-26-000073.md) | [945 d](/filings/0000006281-25-000153.md) | [997](/filings/0000006281-26-000016.md) | [1,380](/filings/0000006281-26-000052.md) | [1,613](/filings/0000006281-26-000073.md) |
| Interest expense | $m | [71.6 d](/filings/0000006281-23-000203.md) | [77.1](/filings/0000006281-24-000034.md) | [77.1](/filings/0000006281-24-000132.md) | [85.2](/filings/0000006281-25-000144.md) | [82.8 d](/filings/0000006281-25-000153.md) | [75.3](/filings/0000006281-26-000016.md) | [74.7](/filings/0000006281-26-000052.md) | [79.6](/filings/0000006281-26-000073.md) | [88.2 d](/filings/0000006281-25-000153.md) | [86.3](/filings/0000006281-26-000016.md) | [87.6](/filings/0000006281-26-000052.md) | [88.7](/filings/0000006281-26-000073.md) |
| Income tax | $m | [73.4 d](/filings/0000006281-25-000153.md) | [50.7](/filings/0000006281-25-000023.md) | [22.4](/filings/0000006281-25-000125.md) | [30.8](/filings/0000006281-25-000144.md) | [38.3 d](/filings/0000006281-25-000153.md) | [44.3](/filings/0000006281-26-000016.md) | [56.2](/filings/0000006281-26-000052.md) | [245](/filings/0000006281-26-000073.md) | [99.5 d](/filings/0000006281-25-000153.md) | [115](/filings/0000006281-26-000016.md) | [148](/filings/0000006281-26-000052.md) | [206](/filings/0000006281-26-000073.md) |
| Net income | $m | [498 d](/filings/0000006281-25-000153.md) | [463](/filings/0000006281-25-000023.md) | [302](/filings/0000006281-25-000125.md) | [392](/filings/0000006281-25-000144.md) | [478 d](/filings/0000006281-25-000153.md) | [391](/filings/0000006281-26-000016.md) | [570](/filings/0000006281-26-000052.md) | [519](/filings/0000006281-26-000073.md) | [788 d](/filings/0000006281-25-000153.md) | [831](/filings/0000006281-26-000016.md) | [1,176](/filings/0000006281-26-000052.md) | [1,340](/filings/0000006281-26-000073.md) |
| Diluted EPS | $ per share | not reported | [0.93](/filings/0000006281-25-000023.md) | [0.61](/filings/0000006281-25-000125.md) | [0.79](/filings/0000006281-25-000144.md) | not reported | [0.78](/filings/0000006281-26-000016.md) | [1.14](/filings/0000006281-26-000052.md) | [1.04](/filings/0000006281-26-000073.md) | not reported | [1.69](/filings/0000006281-26-000016.md) | [2.40](/filings/0000006281-26-000052.md) | [2.74](/filings/0000006281-26-000073.md) |
| Basic EPS | $ per share | not reported | [0.93](/filings/0000006281-25-000023.md) | [0.61](/filings/0000006281-25-000125.md) | [0.79](/filings/0000006281-25-000144.md) | not reported | [0.79](/filings/0000006281-26-000016.md) | [1.15](/filings/0000006281-26-000052.md) | [1.05](/filings/0000006281-26-000073.md) | not reported | [1.70](/filings/0000006281-26-000016.md) | [2.41](/filings/0000006281-26-000052.md) | [2.76](/filings/0000006281-26-000073.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-10-28) | Q1 FY2024 (2024-02-03) | Q2 FY2024 (2024-05-04) | Q3 FY2024 (2024-08-03) | FY2024 (2024-11-02) | Q1 FY2025 (2025-02-01) | Q2 FY2025 (2025-05-03) | Q3 FY2025 (2025-08-02) | FY2025 (2025-11-01) | Q1 FY2026 (2026-01-31) | Q2 FY2026 (2026-05-02) | Q3 FY2026 (2026-08-01) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [1.0](/filings/0000006281-24-000204.md) | [1.3](/filings/0000006281-24-000034.md) | [1.9](/filings/0000006281-24-000132.md) | [2.1](/filings/0000006281-24-000159.md) | [2.0](/filings/0000006281-25-000153.md) | [2.3](/filings/0000006281-25-000023.md) | [2.4](/filings/0000006281-25-000125.md) | [2.3](/filings/0000006281-25-000144.md) | [2.5](/filings/0000006281-26-000073.md) | [2.9](/filings/0000006281-26-000016.md) | [2.4](/filings/0000006281-26-000052.md) | [2.2](/filings/0000006281-26-000073.md) |
| Current assets | $bn | [4.4](/filings/0000006281-24-000204.md) | [4.4](/filings/0000006281-24-000034.md) | [5.2](/filings/0000006281-24-000132.md) | [5.4](/filings/0000006281-24-000159.md) | [5.5](/filings/0000006281-25-000153.md) | [5.7](/filings/0000006281-25-000023.md) | [5.6](/filings/0000006281-25-000125.md) | [6.9](/filings/0000006281-25-000144.md) | [7.1](/filings/0000006281-26-000073.md) | [7.6](/filings/0000006281-26-000016.md) | [7.8](/filings/0000006281-26-000052.md) | [7.1](/filings/0000006281-26-000073.md) |
| Total assets | $bn | [48.8](/filings/0000006281-24-000204.md) | [48.4](/filings/0000006281-24-000034.md) | [48.9](/filings/0000006281-24-000132.md) | [48.6](/filings/0000006281-24-000159.md) | [48.2](/filings/0000006281-25-000153.md) | [48.0](/filings/0000006281-25-000023.md) | [47.3](/filings/0000006281-25-000125.md) | [48.2](/filings/0000006281-25-000144.md) | [48.0](/filings/0000006281-26-000073.md) | [48.0](/filings/0000006281-26-000016.md) | [47.9](/filings/0000006281-26-000052.md) | [48.4](/filings/0000006281-26-000073.md) |
| Current liabilities | $bn | [3.2](/filings/0000006281-24-000204.md) | [2.9](/filings/0000006281-24-000034.md) | [3.3](/filings/0000006281-24-000132.md) | [3.2](/filings/0000006281-24-000159.md) | [3.0](/filings/0000006281-25-000153.md) | [3.0](/filings/0000006281-25-000023.md) | [2.7](/filings/0000006281-25-000125.md) | [3.0](/filings/0000006281-25-000144.md) | [3.2](/filings/0000006281-26-000073.md) | [4.3](/filings/0000006281-26-000016.md) | [4.5](/filings/0000006281-26-000052.md) | [5.7](/filings/0000006281-26-000073.md) |
| Long-term debt | $bn | [5.9](/filings/0000006281-24-000204.md) | [5.9](/filings/0000006281-24-000034.md) | [6.6](/filings/0000006281-24-000132.md) | [6.7](/filings/0000006281-24-000159.md) | [6.6](/filings/0000006281-25-000153.md) | [6.6](/filings/0000006281-25-000023.md) | [6.6](/filings/0000006281-25-000125.md) | [8.1](/filings/0000006281-25-000144.md) | [8.1](/filings/0000006281-26-000073.md) | [7.2](/filings/0000006281-26-000016.md) | [7.2](/filings/0000006281-26-000052.md) | [6.8](/filings/0000006281-26-000073.md) |
| Current portion of debt | $bn | [0.5](/filings/0000006281-24-000204.md) | [0.5](/filings/0000006281-24-000034.md) | [0.9](/filings/0000006281-24-000132.md) | [0.9](/filings/0000006281-24-000159.md) | [0.4](/filings/0000006281-25-000153.md) | [0.4](/filings/0000006281-25-000023.md) | [0.0](/filings/0000006281-25-000125.md) | [0.0](/filings/0000006281-25-000144.md) | [0.0](/filings/0000006281-26-000073.md) | [0.9](/filings/0000006281-26-000016.md) | [0.9](/filings/0000006281-26-000052.md) | [1.3](/filings/0000006281-26-000073.md) |
| Short-term borrowings | $bn | [0.5](/filings/0000006281-24-000204.md) | [0.5](/filings/0000006281-24-000034.md) | [0.5](/filings/0000006281-24-000132.md) | [0.5](/filings/0000006281-24-000159.md) | [0.9](/filings/0000006281-25-000153.md) | [0.5](/filings/0000006281-25-000023.md) | [0.5](/filings/0000006281-25-000125.md) | [0.5](/filings/0000006281-25-000144.md) | [0.4](/filings/0000006281-25-000153.md) | [0.5](/filings/0000006281-26-000016.md) | [0.6](/filings/0000006281-26-000052.md) | [1.0](/filings/0000006281-26-000073.md) |
| Shareholders' equity | $bn | [35.6](/filings/0000006281-24-000204.md) | [35.5](/filings/0000006281-24-000034.md) | [35.2](/filings/0000006281-24-000132.md) | [35.2](/filings/0000006281-24-000159.md) | [35.2](/filings/0000006281-25-000153.md) | [35.1](/filings/0000006281-25-000023.md) | [35.0](/filings/0000006281-25-000125.md) | [34.1](/filings/0000006281-25-000144.md) | [33.8](/filings/0000006281-26-000073.md) | [33.8](/filings/0000006281-26-000016.md) | [33.7](/filings/0000006281-26-000052.md) | [33.6](/filings/0000006281-26-000073.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:CommercialPaper, us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-10-28) | Q1 FY2024 (2024-02-03) | Q2 FY2024 (2024-05-04) | Q3 FY2024 (2024-08-03) | Q4 FY2024 (2024-11-02) | Q1 FY2025 (2025-02-01) | Q2 FY2025 (2025-05-03) | Q3 FY2025 (2025-08-02) | Q4 FY2025 (2025-11-01) | Q1 FY2026 (2026-01-31) | Q2 FY2026 (2026-05-02) | Q3 FY2026 (2026-08-01) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [1,187 d](/filings/0000006281-25-000153.md) | [1,139](/filings/0000006281-25-000023.md) | [808 d](/filings/0000006281-25-000125.md) | [855 d](/filings/0000006281-25-000144.md) | [1,051 d](/filings/0000006281-25-000153.md) | [1,127](/filings/0000006281-26-000016.md) | [819 d](/filings/0000006281-26-000052.md) | [1,165 d](/filings/0000006281-26-000073.md) | [1,701 d](/filings/0000006281-25-000153.md) | [1,369](/filings/0000006281-26-000016.md) | [872 d](/filings/0000006281-26-000052.md) | [1,604 d](/filings/0000006281-26-000073.md) |
| Capital expenditure | $m | [476 d](/filings/0000006281-25-000153.md) | [223](/filings/0000006281-25-000023.md) | [188 d](/filings/0000006281-25-000125.md) | [154 d](/filings/0000006281-25-000144.md) | [165 d](/filings/0000006281-25-000153.md) | [149](/filings/0000006281-26-000016.md) | [90.3 d](/filings/0000006281-26-000052.md) | [79.2 d](/filings/0000006281-26-000073.md) | [215 d](/filings/0000006281-25-000153.md) | [109](/filings/0000006281-26-000016.md) | [138 d](/filings/0000006281-26-000052.md) | [146 d](/filings/0000006281-26-000073.md) |
| Dividends paid | $m | [428 d](/filings/0000006281-25-000153.md) | [426](/filings/0000006281-25-000023.md) | [456 d](/filings/0000006281-25-000125.md) | [456 d](/filings/0000006281-25-000144.md) | [457 d](/filings/0000006281-25-000153.md) | [456](/filings/0000006281-26-000016.md) | [491 d](/filings/0000006281-26-000052.md) | [490 d](/filings/0000006281-26-000073.md) | [487 d](/filings/0000006281-25-000153.md) | [484](/filings/0000006281-26-000016.md) | [536 d](/filings/0000006281-26-000052.md) | [535 d](/filings/0000006281-26-000073.md) |
| Share repurchases | $m | [470 d](/filings/0000006281-25-000153.md) | [180](/filings/0000006281-25-000023.md) | [222 d](/filings/0000006281-25-000125.md) | [118 d](/filings/0000006281-25-000144.md) | [94.9 d](/filings/0000006281-25-000153.md) | [160](/filings/0000006281-26-000016.md) | [249 d](/filings/0000006281-26-000052.md) | [1,075 d](/filings/0000006281-26-000073.md) | [680 d](/filings/0000006281-25-000153.md) | [516](/filings/0000006281-26-000016.md) | [773 d](/filings/0000006281-26-000052.md) | [1,157 d](/filings/0000006281-26-000073.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-01-28) | Q2 FY2023 (2023-04-29) | Q3 FY2023 (2023-07-29) | Q1 FY2024 (2024-02-03) | Q2 FY2024 (2024-05-04) | Q3 FY2024 (2024-08-03) | Q1 FY2025 (2025-02-01) | Q2 FY2025 (2025-05-03) | Q3 FY2025 (2025-08-02) | Q1 FY2026 (2026-01-31) | Q2 FY2026 (2026-05-02) | Q3 FY2026 (2026-08-01) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [511](/filings/0000006281-24-000034.md) | [509](/filings/0000006281-24-000132.md) | [504](/filings/0000006281-24-000159.md) | [499](/filings/0000006281-25-000023.md) | [499](/filings/0000006281-25-000125.md) | [499](/filings/0000006281-25-000144.md) | [499](/filings/0000006281-26-000016.md) | [498](/filings/0000006281-26-000052.md) | [497](/filings/0000006281-26-000073.md) | [492](/filings/0000006281-26-000016.md) | [490](/filings/0000006281-26-000052.md) | [489](/filings/0000006281-26-000073.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 484,565,465 at 2026-08-01, from the cover of the [10-Q filed 2026-08-19](/filings/0000006281-26-000073.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:17 ET. No prices; not investment advice.